SV2A
-
ADHD, adverse events, antiseizure medication, Brain, children with epilepsy, Drugs, epilepsy, levetiracetam, neuroscience, oxcarbazepine, pediatric epilepsy, SV2A, therapeutic drug monitoring, topiramateLevetiracetam Range in Children: 2.82-24.37 mcg/mL TDM
A 2026 real-world study involving 1,174 children with epilepsy proposed a levetiracetam…
